IP Verse

Compositions Comprising Synthetic Polynucleotides Encoding Crispr Related Proteins And Synthetic Sgrnas And Methods Of Use - EP3019619B1

PatentPatent Analysis

EP3019619

MODERNA THERAPEUTICS
Application Number
EP14823392A
Filing Date
Jul 11, 2014
Status
Granted And Under Opposition
Jul 23, 2021
Grant Date
Aug 25, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2791160B1
EP2922554B1
EP3492109B1

Bibliography

The patent EP3019619B1 was granted to Moderna Therapeutics on Aug 25, 2021 following the initial filing on Jul 11, 2014 under the application number EP14823392A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDMay 25, 2022ADMISSIBLE
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBApr 1, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents